Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 1998

View Archived Issues

Company Profile: ArQule

Company Profile: Avax Technologies

Cytogen: Q4 and year-end 1997 highlights

Cholera toxin enhances transcutaneous delivery, enabling development of needle-free vaccines

Acetaminophen increases risk of hemorrhage in combination with warfarin

Anika: year-end 1997 highlights

ArQule and Sepracor to optimize lead antiinfective compounds

Phase I results reported for alpha-gal in Fabry's disease

Status of Oncolym updated

J&J to withdraw from pramlintide collaboration; exendin update

Cell Therapeutics: Q4 and year-end 1997 highlights

University of Alabama describes delta-EKLFs for hemoglobinopathies

3-D reveals new trypsin-like serine protease inhibitors

Vaccines for group B meningococcal infection disclosed

Kowa product pipeline in review

Antidiabetic agents in development at Boehringer Mannheim

DiagnoCure signs agreements related to development of targeted nanoerythrosomes

More light shed on Lp(a) and its role in heart disease

Flavonoid intake reduces risk of death from CHD

Searle uses Epimmune technologies to develop cancer therapies

More on anti-HIV research at Glaxo Wellcome

BOPP will enter clinical testing in cancer patients

Gliadel Wafer approved for marketing in Brazil

Distribution and marketing of terfenadine-containing products discontinued in U.S.

Watson acquires Hoechst Marion Roussel's U.S. generic drug subsidiary

Efficacy of immunoliposomal amphotericin B confirmed in mice with invasive aspergillosis

Liposomal ciprofloxacin formulations demonstrate high efficacy and versatility

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...